These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27311527)

  • 21. Cardiovascular magnetic resonance imaging for detection of myocardial viability in chronic ischemic left ventricular dysfunction.
    Glaveckaite S; Valeviciene N; Laucevicius A; Celutkiene J; Rudys A; Tamosiūnas A
    Medicina (Kaunas); 2009; 45(8):585-99. PubMed ID: 19773617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of myocardial viability.
    Beller GA
    Curr Opin Cardiol; 1997 Sep; 12(5):459-67. PubMed ID: 9352173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial viability: contractile reserve or cell membrane integrity?
    Dilsizian V
    J Am Coll Cardiol; 1996 Aug; 28(2):443-6. PubMed ID: 8800123
    [No Abstract]   [Full Text] [Related]  

  • 24. Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.
    Maruskova M; Gregor P; Bartunek J; Tintera J; Penicka M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):62-8. PubMed ID: 19577058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible left ventricular dysfunction in the setting of coronary occlusive disease.
    Bache RJ
    J Card Fail; 1998 Sep; 4(3):155-8. PubMed ID: 9754585
    [No Abstract]   [Full Text] [Related]  

  • 26. Coronary revascularization in ischemic cardiomyopathy.
    Westaby S
    Surg Clin North Am; 2004 Feb; 84(1):179-99, x. PubMed ID: 15053189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The basis of chronic ischemic reversible left ventricular dysfunction (hibernating myocardium)].
    Mates M; Veselka J
    Cesk Fysiol; 1999 Feb; 48(1):4-8. PubMed ID: 10377599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of myocardial viability in postinfarction and indications of revascularization].
    Zouaoui W; Ouldzein H; Carrié D
    Ann Cardiol Angeiol (Paris); 2010 Apr; 59(2):79-85. PubMed ID: 18980750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies.
    Orlandini A; Castellana N; Pascual A; Botto F; Cecilia Bahit M; Chacon C; Luz Diaz M; Diaz R
    Int J Cardiol; 2015 Mar; 182():494-9. PubMed ID: 25617608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods of assessment and clinical relevance of myocardial hibernation and stunning. Assessment of myocardial viability.
    Baer FM; Erdmann E
    Thorac Cardiovasc Surg; 1998 Sep; 46 Suppl 2():264-9. PubMed ID: 9822177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global myocardial function, regional myocardial function, and the Daemon of Laplace.
    Voigt JU
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):633-4. PubMed ID: 27076366
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronary artery surgery for ischemic heart failure: risks, benefits, and the importance of assessment of myocardial viability.
    Pitt M; Lewis ME; Bonser RS
    Prog Cardiovasc Dis; 2001; 43(5):373-86. PubMed ID: 11251125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.
    Demirkol MO
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that stunning can be cumulative in man.
    Rinaldi CA; Hall RJ
    Heart Fail Rev; 2003 Apr; 8(2):161-5. PubMed ID: 12766495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical Implications of Myocardial Viability Studies.
    Ker WDS; Nunes THP; Nacif MS; Mesquita CT
    Arq Bras Cardiol; 2018 Mar; 110(3):278-288. PubMed ID: 29694555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism.
    Pasquet A; Lauer MS; Williams MJ; Secknus MA; Lytle B; Marwick TH
    Eur Heart J; 2000 Jan; 21(2):125-36. PubMed ID: 10637086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
    Slart RH; Zeebregts CJ; Hillege HL; de Sutter J; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Tio RA
    J Nucl Med; 2011 Jun; 52(6):873-9. PubMed ID: 21571798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial hibernation: a clinician's perspective.
    Beller GA
    Ital Heart J; 2002 May; 3(5):291-3. PubMed ID: 12066560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiac decompensation: mechanism of reversibility].
    Melin J; Vanoverschelde JL
    Bull Mem Acad R Med Belg; 1997; 152(1):101-8; discussion 108-11. PubMed ID: 9491624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.